Calendar

pharmadog

Week of Feb 21, 2022

Feb 25, 2022approval1629d agoAMPHETAMINE SULFATE — FDA approvalamfetamine ER

Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

full page →amfetamine ER →fda approvals ↗

Feb 25, 2022approval1629d agoAMPHETAMINE SULFATE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2022approval1629d agoAMPHETAMINE SULFATE — FDA approvalAurolife Pharma LLC

Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2022approval1629d agoAMPHETAMINE SULFATE — FDA approvalamfetamine ER

Sponsor: GRANULES. Form: TABLET. Route: ORAL

full page →amfetamine ER →fda approvals ↗

Feb 25, 2022approval1629d agoAMPHETAMINE SULFATE — FDA approvalAurolife Pharma LLC

Sponsor: DR REDDYS LABS SA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2022approval1629d agoDEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE) — FDA approvalMallinckrodt LLC

Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Feb 25, 2022approval1629d agoVYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 25, 2022approval1629d agoDYANAVEL XR 20 (AMPHETAMINE) — FDA approvalDYANAVEL XR 20

Sponsor: TRIS PHARMA INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DYANAVEL XR 20 →fda approvals ↗

Feb 25, 2022approval1629d agoADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Feb 25, 2022approval1629d agoVYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: TABLET, CHEWABLE. Route: ORAL

full page →fda approvals ↗

Feb 25, 2022approval1629d agoDYANAVEL XR (AMPHETAMINE) — FDA approvalamfetamine ER

Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL

full page →amfetamine ER →fda approvals ↗

Feb 25, 2022approval1629d agoADZENYS XR-ODT (AMPHETAMINE) — FDA approvalTraws Pharma, Inc.

Sponsor: NEOS THERAPS. Form: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Week of Feb 28, 2022

Feb 28, 2022approval1626d agoVONJO (PACRITINIB CITRATE) — FDA approvalpacritinib

Sponsor: SOBI. Form: CAPSULE. Route: ORAL

full page →pacritinib →fda approvals ↗

Feb 28, 2022approval

Week of Mar 7, 2022

Mar 8, 2022approval1618d agoPREGABALIN — FDA approvalPREGABALIN

Sponsor: ESKAYEF. Form: CAPSULE. Route: ORAL

full page →PREGABALIN →fda approvals ↗

Mar 8, 2022approval

Week of Mar 14, 2022

Mar 15, 2022approval1611d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →ondansetron hydrochloride CR →fda approvals ↗

Mar 15, 2022approval

Week of Mar 21, 2022

Mar 21, 2022approval1605d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗

Mar 21, 2022approval

← prev

page 4 of 520

Week of Feb 21, 2022

Week of Feb 28, 2022

Week of Mar 7, 2022

Week of Mar 14, 2022

Week of Mar 21, 2022